Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Addus HomeCare Corporation - Common Stock (NQ: ADUS )

113.22 -2.27 (-1.97%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 148,957
Open 116.14
Bid (Size) 45.34 (2)
Ask (Size) 112.77 (1)
Prev. Close 115.49
Today's Range 112.91 - 116.81
52wk Range 85.94 - 136.72
Shares Outstanding 16,204,341
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Senior Health, Home Health & Hospice Stocks Q3 Results: Benchmarking Brookdale (NYSE:BKD)
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Brookdale (NYSE:BKD) and its peers. 
Via StockStory
Topics Economy
Exposures Interest Rates
Q3 Earnings Highs And Lows: Chemed (NYSE:CHE) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks
Looking back on senior health, home health & hospice stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Chemed (NYSE:CHE) and its peers. 
Via StockStory
Topics Economy
Exposures Interest Rates

Performance

YTD
-8.88%
-8.88%
1 Month
-15.08%
-15.08%
3 Month
-4.27%
-4.27%
6 Month
-14.26%
-14.26%
1 Year
+20.06%
+20.06%

More News

Read More
Senior Health, Home Health & Hospice Stocks Q3 Teardown: BrightSpring Health Services (NASDAQ:BTSG) Vs The Rest
Via StockStory
Topics Economy
Exposures Interest Rates
Q3 Earnings Highlights: Addus HomeCare (NASDAQ:ADUS) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks
Via StockStory
Topics Economy
Exposures Interest Rates
Deep Dive Into Addus HomeCare Stock: Analyst Perspectives (6 Ratings)
Via Benzinga
Is NASDAQ:ADUS a Suitable Choice for Quality Investing?
Via Chartmill
Addus HomeCare Announces Fourth Quarter and Year-end 2024 Earnings Release and Conference Call
From Addus HomeCare Corporation
Via Business Wire
DaVita Stock Sees Improved Relative Strength Rating
Via Investor's Business Daily
Should you consider ADDUS HOMECARE CORP (NASDAQ:ADUS) for quality investing?
Via Chartmill
As US Faces Shortage Of Expensive Skilled Clinicians, Home-Based Health Service Provider Addus HomeCare Is Well-Positioned To Grow: Analyst
Via Benzinga
This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Assessing Addus HomeCare: Insights From 9 Financial Analysts
Via Benzinga
The Analyst Verdict: Addus HomeCare In The Eyes Of 9 Experts
Via Benzinga
Demystifying Addus HomeCare: Insights From 8 Analyst Reviews
Via Benzinga
Addus HomeCare Completes Acquisition of Personal Care Operations of Gentiva
From Addus HomeCare Corporation
Via Business Wire
Addus HomeCare to Participate in Stephens Annual Investment Conference
From Addus HomeCare Corporation
Via Business Wire
Addus HomeCare Announces Third Quarter 2024 Financial Results
From Addus HomeCare Corporation
Via Business Wire
Addus HomeCare Announces Third Quarter 2024 Earnings Release and Conference Call
From Addus HomeCare Corporation
Via Business Wire
Cracking The Code: Understanding Analyst Reviews For Addus HomeCare
Via Benzinga
Analyst Scoreboard: 6 Ratings For Addus HomeCare
Via Benzinga
Exploring ADDUS HOMECARE CORP (NASDAQ:ADUS)s quality characteristics.
Via Chartmill
AdaptHealth Stock Earns RS Rating Upgrade
Via Investor's Business Daily
Reasonable growth and debt and a high ROIC for ADDUS HOMECARE CORP (NASDAQ:ADUS).
Via Chartmill
ADUS Stock Earnings: Addus HomeCare Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Addus HomeCare Announces Second Quarter 2024 Financial Results
From Addus HomeCare Corporation
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.